Document ID: chunk:federal_register_of_legislation:F2025C00214:clause:1_61369
Version: federal_register_of_legislation:F2025C00214
Segment Type: clause
Provision Reference: sch 1 cl 61369
Character Range: 281333–282260

61369                                Indium‑labelled octreotide study (including single photon emission tomography when undertaken), if:                                                                                                                                                                                                                                                                                           2,086.30
                                     (a) a gastro‑entero‑pancreatic endocrine tumour is suspected on the basis of biochemical evidence with negative or equivocal conventional imaging; or
                                     (b) both:
                                     (i) a surgically amenable gastro‑entero‑pancreatic endocrine tumour has been identified on the basis of conventional techniques; and
                                     (ii) the study is to exclude additional disease sites (R)